首页> 外文期刊>International Journal of Basic & Clinical Pharmacology >Prevalence of functional constipation and constipation-predominant irritable bowel syndrome in Indian patients with constipation
【24h】

Prevalence of functional constipation and constipation-predominant irritable bowel syndrome in Indian patients with constipation

机译:印度便秘患者的功能性便秘和以便秘为主的肠易激综合征的患病率

获取原文
       

摘要

Background: Evaluate prevalence of functional constipation (FC) and irritable bowel syndrome-constipation (IBS-C) in Indian constipated patients and assess their demographic/socio-economic/clinical characteristics. Methods: Patients (≥18 years) who visited their general physician with symptoms of constipation (Rome III criteria for FC or IBS-C as per physician assessment) and willing to participate were enrolled in this prospective, clinical-epidemiological study. Demographic, socioeconomic status, lifestyle and dietary habits, comorbid conditions, treatment history, concomitant medications, stool form (Bristol stool form scale), severity of constipation (constipation scoring system [CSS]), constipation-related symptoms (patient assessment of constipation symptoms [PAC-SYM]) and quality of life (patient assessment of constipation-quality of life questionnaire [PAC-QoL]) were recorded. Results: Out of 925 constipated patients, 75.6% were diagnosed with FC against 24.4% with IBS-C (P < 0.0001). Patients of both subtypes had high average scores of PAC-SYM (FC: 27.1 ± 6; IBS-C: 30.1 ± 4.9) and CSS (FC: 8.4 ± 3.1; IBS-C: 11.2 ± 3), leading to high PAC-QoL score (FC: 38.1 ± 16.8; IBS-C: 42.2 ± 13.6). Hypertension (16%) and diabetes (10%) in patients with FC while acid peptic disorders (21.7%) amongst IBS-C patients were the most common comorbid conditions observed. Laxatives were the most common medication used; osmotic (32.6% versus 40.7%) and bulk laxatives (22.8% versus 37.4%) were the commonest laxatives. However, about 1/5th patients of FC were using home remedies. Conclusions: There was a higher prevalence of FC over IBS-C in Indian constipated patients; both subtypes had high frequency and severity of constipation-related symptoms and poor QoL.
机译:背景:评估印度便秘患者的功能性便秘(FC)和肠易激综合征(IBS-C)的患病率,并评估其人口统计学/社会经济/临床特征。方法:本次前瞻性临床流行病学研究招募了就诊便秘(≥18岁)且便秘症状(根据医师评估,罗马III标准的FC或IBS-C标准)并且愿意参加的患者。人口统计学,社会经济状况,生活方式和饮食习惯,合并症,治疗史,伴随用药,粪便形式(布里斯托尔粪便形式量表),便秘的严重程度(便秘评分系统[CSS]),便秘相关症状(便秘症状的患者评估)记录[PAC-SYM]和生活质量(患者对便秘质量生活问卷的评估[PAC-QoL])。结果:在925名便秘患者中,诊断为FC的占75.6%,而IBS-C诊断为24.4%(P <0.0001)。两种亚型患者的PAC-SYM(FC:27.1±6; IBS-C:30.1±4.9)和CSS(FC:8.4±3.1; IBS-C:11.2±3)的平均得分均较高,导致PAC-SYM较高QoL分数(FC:38.1±16.8; IBS-C:42.2±13.6)。在FC患者中,高血压(16%)和糖尿病(10%),而IBS-C患者中的酸性消化系统疾病(21.7%)是最常见的合并症。泻药是最常用的药物。渗透性(32.6%对40.7%)和散装泻药(22.8%对37.4%)是最常见的泻药。但是,约1/5的FC患者正在使用家庭疗法。结论:印度便秘患者的FC患病率高于IBS-C。两种亚型都与便秘相关症状的发生频率和严重程度较高,并且生活质量较差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号